Viking Therapeutics (NASDAQ:VKTX) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Viking Therapeutics (NASDAQ:VKTX – Get Free Report) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.26) by $0.06, Briefing.com reports. During the same quarter last year, the firm posted ($0.19) earnings per share. Viking Therapeutics Stock Up 28.3 % […]

Leave a Reply

Your email address will not be published.

Previous post Trustmark (NASDAQ:TRMK) Posts Earnings Results, Beats Expectations By $0.03 EPS
Next post Viking Therapeutics (NASDAQ:VKTX) Announces Earnings Results